body by design semaglutide Injection in Memphis Semaglutide for weight loss |

In clinical trials, patients on tirzepatide lost an average of 20 to 22 percent of their body weight over approximately 72 weeks

Half of GLP-1 users report increased confidence since starting the medication, while two out of five experienced improvements in libido or sexual satisfaction

In Britain, when the first NICE Guidelines for Schizophrenia were being produced, Lilly threatened to pull out of Britain if Zyprexa did not feature as a first line treatment for the condition

Since 2020, the number of prescriptions made for GLP-1 drugs has more than tripled

Reports by themselves are not an indicator of a medical products safety profile